CJC-1295 + Ipamorelin (Combo)

Growth Hormone Secretagogue Combinationresearch

Also known as: CJC/Ipa, CJC-1295/Ipamorelin Stack, GH Peptide Combo, The Gold Standard Stack

The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.

SponsoredPartner with us — advertise hereContact us

Overview

The CJC-1295 + Ipamorelin combination is widely considered the 'gold standard' peptide stack for growth hormone optimization. CJC-1295 (no DAC / Mod GRF 1-29) acts as a growth hormone releasing hormone (GHRH) analog that amplifies the GH pulse, while Ipamorelin acts as a growth hormone releasing peptide (GHRP) that initiates the pulse by mimicking ghrelin at the pituitary. Together, they produce a synergistic effect — releasing significantly more GH than either peptide alone — while maintaining the natural pulsatile pattern of GH secretion. This combination is preferred over other GHRP options (GHRP-2, GHRP-6, Hexarelin) because Ipamorelin causes minimal hunger stimulation, no cortisol or prolactin elevation, and fewer side effects. The combo is used for anti-aging, body composition improvement, sleep enhancement, recovery, and overall vitality.

Mechanism of Action

Dual-pathway GH release: (1) CJC-1295 binds GHRH receptors on pituitary somatotrophs, amplifying growth hormone synthesis and release via cAMP/PKA signaling; (2) Ipamorelin binds GHS-R1a (ghrelin receptors) on pituitary somatotrophs, initiating GH pulse through a complementary PLC/IP3/PKC pathway; (3) The two pathways converge synergistically, producing GH output greater than the sum of individual effects; (4) Combined signaling maintains natural pulsatile GH secretion rather than creating a sustained, unnatural elevation; (5) Downstream IGF-1 production increases from liver stimulation; (6) Ipamorelin selectively stimulates GH without significantly affecting ACTH, cortisol, or prolactin.

Molecular Formula

Combination product

Molecular Weight

CJC-1295: 3367.9 g/mol; Ipamorelin: 711.85 g/mol

Sequence

CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2

Dosage Protocols

Dose Range

100mcg CJC + 100mcg Ipa200mcg CJC + 200mcg Ipa

Frequency

Once daily at bedtime

Route

subcutaneous

Cycle Length

8-12 weeks on, 4 weeks off

Inject on an empty stomach (2+ hours fasted). Bedtime dosing amplifies natural nocturnal GH pulse. Avoid carbs/fats 30 min before and after injection.

Source: Clinical anti-aging protocols

🧮 Personalized Dosage Calculator

💰 Estimated Pricing

$100 – $350per month supplytelehealth/compounding

Typical Supply

Combination vial or separate vials

Last Updated

2026-02

Most popular GH-releasing combo. Telehealth: $150-350/mo. Compounding pharmacy combo vials available. Often prescribed together.

⚠️ Prices are estimates based on publicly available data and may vary significantly by vendor, location, and prescription status. This is not medical or financial advice.

Side Effects

EffectSeverity
Injection site rednessmild
Head rush / flushingmild
Water retentionmild
Numbness/tingling in extremitiesmild
Hunger increasemild
Vivid dreamsmild

Pros & Cons

Synergistic GH release far exceeding either peptide alone — the most effective non-HGH GH optimization

Maintains natural pulsatile GH secretion pattern unlike exogenous HGH

Ipamorelin is the cleanest GHRP — no significant cortisol, prolactin, or appetite side effects

Broad benefits spanning sleep, body composition, recovery, skin, and anti-aging

Significantly less expensive than exogenous HGH therapy

Requires multiple daily subcutaneous injections for optimal results

Must be injected on an empty stomach for maximal GH release — timing can be inconvenient

GH levels produced are still lower than pharmacological HGH doses

Cycling is recommended to prevent pituitary desensitization

Not FDA-approved; regulatory and quality concerns with research-grade peptides

Research Studies

🩸 Blood Work

RecommendedRetest: IGF-1 and fasting glucose at 4-6 weeks, then every 3 months
🧬

IGF-1

Primary marker for GH axis activity — combo produces strong GH release

🔬

Fasting Blood Glucose

GH secretagogues can impair insulin sensitivity

🔬

Fasting Insulin

Monitor for insulin resistance

🧬

Thyroid Panel (TSH, T3, T4)

GH can affect thyroid hormone conversion

🧬

Cortisol

Ipamorelin is selective but combo may affect HPA axis

Popular GH secretagogue combination. The GHRH + GHRP synergy produces stronger GH release than either alone. Monitor IGF-1 to ensure levels stay in a safe range.

Legal Status

Neither peptide is FDA-approved. Available through compounding pharmacies with prescription or as research chemicals. Banned by WADA for competitive athletes.

Readers Also Viewed

Related Peptides

SponsoredPartner with us — advertise hereContact us